Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIAMCINOLONE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 1,886 adverse event reports in the FDA FAERS database where TRIAMCINOLONE was used for Psoriasis.

Most Reported Side Effects for TRIAMCINOLONE

Side Effect Reports % Deaths Hosp.
Drug ineffective 3,035 45.4% 159 555
Psoriasis 1,131 16.9% 19 328
Off label use 901 13.5% 116 458
Product use in unapproved indication 724 10.8% 170 186
Condition aggravated 625 9.3% 76 396
Therapeutic product effect incomplete 624 9.3% 110 152
Treatment failure 612 9.2% 151 101
Drug intolerance 527 7.9% 166 373
Nausea 525 7.9% 122 411
Pruritus 485 7.3% 45 57
Vomiting 485 7.3% 148 419
Synovitis 478 7.1% 179 403
Arthralgia 461 6.9% 144 134
Adrenal insufficiency 459 6.9% 22 385
Obesity 455 6.8% 129 373

Other Indications for TRIAMCINOLONE

Product used for unknown indication (1,376) Juvenile idiopathic arthritis (246) Rheumatoid arthritis (156) Psoriatic arthropathy (149) Migraine (116) Eczema (110) Hidradenitis (108) Dermatitis atopic (92) Cystoid macular oedema (83) Back pain (78)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

TRIAMCINOLONE Full Profile All Psoriasis Drugs TRIAMCINOLONE Demographics TRIAMCINOLONE Timeline